The Adaptive Care Transition Strategy Sprint

Does this sound like your post-acute portfolio?

Your 30-day readmission rate has plateaued despite discharge-planning investments that keep growing.
Post-discharge calls check logistics — the ride, the prescription, the follow-up — and escalations still "come out of nowhere."
You suspect caregiver strain drives a large share of returns, but nothing in your data shows it.
Every vendor pitch requires new software, new integrations, and eighteen months you don't have.

Home · Day 14 of 30

Why it's missed

Escalation looks sudden from the hospital. From the home, it was visible for days.

Discharge planning treats caregivers as logistics. Necessary — and not the problem. The person now running the medication schedule and absorbing every fluctuation is operating with a nervous system under chronic load. That load is silent until it isn't.

Early-warning signals in a caregiver's daily patterns precede an escalation event by 3–7 days. Nobody is measuring the right thing. That window is the opportunity.

Introducing

A 10-week engagement that makes caregiver capacity visible as a clinical signal — and designs staff-deliverable interventions timed to the moments the data says matter.

No procurementNothing new to buy, connect, or install — signals come from tools patients already use.

Cohort-first50–100 caregivers followed through the 30-day window before anything scales.

Staff-deliverableInterventions land inside existing workflow — not another app the caregiver won't open.

You own the outputsROI model and a publication-ready case study your team can defend internally.

How the engagement unfolds

Ten weeks, four phases.

01.

Discovery

Weeks 1–2

Executive alignment, workflow shadowing, data access, and definition of the target discharge cohort.

02.

Proof

Weeks 2–6

50–100 caregivers followed through the 30-day window using light-touch signals plus friction logging. First live readings of caregiver load across the transition.

03.

Design

Weeks 5–8

Intervention design tied to the signal: what triggers, who delivers it, and how it lands inside existing staff workflow.

04.

Results

Weeks 8–14

Outcome measurement, ROI model, and a publication-ready case study you own and can replicate across service lines.

Every sprint includes three assets most engagements charge for.

Included · Deliverable 01

The Workflow Blind-Spot Map

Your actual discharge-to-day-30 path, annotated with the handoffs and moments a caregiver holds a clinical decision without training.

Included · Deliverable 02

The Caregiver Risk Ledger

Who escalates, when, and on what signal — the cohort-level evidence base your quality team keeps using after the sprint ends.

Included · Deliverable 03

The Replication Blueprint

Everything required to run the program on a second service line without me in the room.

Investment

Two ways to begin.

Scope is fixed, cohort-level proof comes before scale, and outputs are yours. Figures on expected outcomes (15–25% readmission reduction; 1.6–2.4× return) are illustrative pending first pilot — and we'll say so in the room, too.

Step one · No cost

20 minutes

One conversation about your discharge cohort, your current readmission numbers, and whether this engagement fits. If it doesn't, you'll leave with the blind-spot framing anyway.

Book the call

The engagement

10-week sprint

Full four-phase engagement, one health system per quarter. Pricing scoped to cohort size and data environment on the discovery call — no surprises after week one.

Start the conversation

Christine Galligan, MHA

Who's doing the work

Fourteen years inside healthcare's hardest transitions.

Christine Galligan, MHA. Work spanning Philips, CVS Health innovation, and multi-year caregiver stress research — behavioral-science rigor combined with the operational reality of moving programs through a health system, from executive sponsorship to frontline adoption.

CVS Health · 70M+ members · 15%+ adherence lift — Philips · 20+ ventures — Somatag · patent pending

Part of Kutuhala Studio's inquiry into adaptive systems for human capacity.

Still have questions?

Do we need new software or integrations?

No. The proof cohort runs on light-touch signals patients and caregivers already generate, plus structured friction logging. Nothing to procure, connect, or install.

What does this ask of our staff?

Discovery requires shadowing access and a working group of 3–5 people for weekly 30-minute sessions. Interventions are designed to fit existing workflow — reducing, not adding, escalation load.

What if the signal doesn't show in our cohort?

Then you'll know by week six, at cohort scale, before spending on rollout — with the workflow map and risk ledger in hand regardless. That's the point of proof-before-scale.

Is this research or consulting?

Consulting with research rigor: methods are documented, measurement is pre-defined, and the case study is written to publication standard so your team can defend it internally and externally.

Who owns the data and outputs?

You do. All deliverables, the ROI model, and the case study belong to your organization.

Your readmissions problem is a visibility problem.

Does this sound like your post-acute portfolio?

Escalation looks sudden from the hospital. From the home, it was visible for days.